Astolfi A; Rolla S; Nanni P; Quaglino E; De Giovanni C; Iezzi M; Musiani P; Forni G; Lollini PL; Cavallo F; Calogero RA., Immune prevention of mammary carcinogenesis in HER-2/neu transgenic mice: a microarray scenario., «CANCER IMMUNOLOGY, IMMUNOTHERAPY», 2005, 54, pp. 599 - 610 [articolo]
P.L. Lollini, Immune response to tumor, in: H.W. VOHR, Encyclopedic reference of immunotoxicology, HEIDELBERG, Springer, 2005, pp. 670 - 674 [voce di enciclopedia/dizionario]
Pappalardo F; Lollini PL; Castiglione F; Motta S., Modeling and simulation of cancer immunoprevention vaccine., «BIOINFORMATICS», 2005, 21, pp. 2891 - 2897 [articolo]
S. Motta; F. Castiglione; P.-L. Lollini; F. Pappalardo, Modelling vaccination schedules for a cancer immunoprevention vaccine., «IMMUNOME RESEARCH», 2005, 1, pp. 1 - 18 [articolo]
Lollini PL; Nicoletti G; Landuzzi L; De Giovanni C; Nanni P., New target antigens for cancer immunoprevention, «CURRENT CANCER DRUG TARGETS», 2005, 5, pp. 221 - 228 [articolo]
P.-L. Lollini, Terapia genica, in: Le biotecnologie e la qualità della vita, BOLOGNA, Patron Editore, 2005, pp. 129 - 138 [capitolo di libro]
Casadio F; Croci S; D'Errico Grigioni A; Corti B; Grigioni WF; Landuzzi L; Lollini PL., Toward the definition of immunosuppressive regimens with antitumor activity., «TRANSPLANTATION PROCEEDINGS», 2005, 37, pp. 2144 - 2147 [articolo]
Cuadros C; Dominguez AL; Lollini PL; Croft M; Mittler RS; Borgstrom P; Lustgarten J., Vaccination with dendritic cells pulsed with apoptotic tumors in combination with anti-OX40 and anti-4-1BB monoclonal antibodies induces T cell-mediated protective immunity in Her-2/neu transgenic mice., «INTERNATIONAL JOURNAL OF CANCER», 2005, 116, pp. 934 - 943 [articolo]
DE GIOVANNI, Carla; Landuzzi, Lorena; Nicoletti, G.; Astolfi, Annalisa; Croci, Stefania; Micaroni, M.; Nanni, Patrizia; Lollini, PIER LUIGI, Apc10.1: an ApcMin/+ intestinal cell line with retention of heterozygosity., «INTERNATIONAL JOURNAL OF CANCER», 2004, 109, pp. 200 - 206 [articolo]
QUAGLINO E.; ROLLA S.; IEZZI M.; SPADARO M.; MUSIANI P.; DE GIOVANNI C.; LOLLINI P.L.; LANZARDO S.; FORNI G.; SANGES R.; CRISPI S.; DE LUCA P.; CALOGERO R.; CAVALLO F., Concordant morphologic and gene expression data show that a vaccine halts HER-2/neu preneoplastic lesions., «THE JOURNAL OF CLINICAL INVESTIGATION», 2004, 113, pp. 709 - 717 [articolo]
Quaglino E; Iezzi M; Mastini C; Amici A; Pericle F; Di Carlo E; Pupa SM; De Giovanni C; Spadaro M; Curcio C; Lollini PL; Musiani P; Forni G; Cavallo F., Electroporated DNA vaccine clears away multifocal mammary carcinomas in her-2/neu transgenic mice., «CANCER RESEARCH», 2004, 64, pp. 2858 - 2864 [articolo]
CROCI S; NICOLETTI G; LANDUZZI L; DE GIOVANNI C; ASTOLFI A; MARINI C; DI CARLO E; MUSIANI P; FORNI G; NANNI P.; LOLLINI P-L, Immunological prevention of a multigene cancer syndrome, «CANCER RESEARCH», 2004, 64, pp. 8428 - 8434 [articolo]
DE GIOVANNI C; NICOLETTI G; LANDUZZI L; ASTOLFI A; CROCI S; COMES A; FERRINI S; MEAZZA R; IEZZI M; DI CARLO E; MUSIANI P; CAVALLO F; NANNI P.; LOLLINI P-L, Immunoprevention of HER-2/neu transgenic mammary carcinoma through an interleukin 12 engineered allogeneic cell vaccine, «CANCER RESEARCH», 2004, 64, pp. 4001 - 4009 [articolo]
NANNI P.; LANDUZZI L; NICOLETTI G; DE GIOVANNI C; ROSSI I; CROCI S; ASTOLFI A; IEZZI M; DI CARLO E; MUSIANI P; FORNI G; LOLLINI P-L, Immunoprevention of mammary carcinoma in HER-2/neu transgenic mice is IFN-gamma and B cell dependent, «JOURNAL OF IMMUNOLOGY», 2004, 173, pp. 2288 - 2296 [articolo]
CROCI S; LANDUZZI L; ASTOLFI A; NICOLETTI G; ROSOLEN A; SARTORI F; FOLLO MY; OLIVER N; DE GIOVANNI C; NANNI P.; LOLLINI P-L, Inhibition of connective tissue growth factor (CTGF/CCN2) expression decreases the survival and myogenic differentiation of human rhabdomyosarcoma cells, «CANCER RESEARCH», 2004, 64, pp. 1730 - 1736 [articolo]
